Active, not recruitingPhase 2NCT01419067
A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma or Observation After Radical Resection
Studying Craniopharyngioma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- St. Jude Children's Research Hospital
- Principal Investigator
- Thomas E Merchant, DO, PhD, DOSt. Jude Children's Research Hospital
- Intervention
- Radical Surgery or Limited Surgery(procedure)
- Enrollment
- 112 enrolled
- Eligibility
- 21 years · All sexes
- Timeline
- 2011 – 2026
Study locations (2)
- University of Florida Health Proton Therapy Institute, Jacksonville, Florida, United States
- St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01419067 on ClinicalTrials.govOther trials for Craniopharyngioma
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07177482ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma PatientsDeling Li
- RECRUITINGNCT06801756Craniopharyngioma and PregnanciesAssistance Publique - Hôpitaux de Paris
- RECRUITINGPHASE2NCT05525273Treatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary CraniopharyngiomaEva Marie Erfurth, MD, PhD
- RECRUITINGPHASE2NCT05465174Tovorafenib for Treatment of Craniopharyngioma in Children and Young AdultsSabine Mueller, MD, PhD
- ENROLLING BY INVITATIONNCT03610906Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical TherapyUniversity of Colorado, Denver
- ACTIVE NOT RECRUITINGPHASE2NCT03224767Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive CraniopharyngiomaAlliance for Clinical Trials in Oncology
- ACTIVE NOT RECRUITINGPHASE2NCT02792582A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical ResectionSt. Jude Children's Research Hospital